Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00542776 · ClinicalTrials.gov registry record
Impact of Immunosuppression in IBD Patients on Response to Influenza Vaccine
A clinical trial of Inflammatory Bowel Disease (IBD) and Influenza Vaccine, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 146
- Enrollment target
- 1
- Study location
NCT00542776 is a study of Inflammatory Bowel Disease (IBD) and Influenza Vaccine that has completed, run by Boston Children's Hospital. The registered enrollment target is 146 participants, below the 262-participant average among 12 other Inflammatory Bowel Disease (IBD) trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00542776, a study of Inflammatory Bowel Disease (IBD) and Influenza Vaccine, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 146 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the efficacy and safety of influenza vaccine in patients with inflammatory bowel disease (IBD) on immunosuppressive therapy with IBD patients on aminosalicylates and healthy historical controls.
Conditions Studied
Interventions
- OTHER blood draw
Study Locations (1)
Massachusetts
- Children's Hospital Boston - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2007-10 |
| Est. Completion | 2008-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00542776
The ClinicalTrials.gov registry entry for NCT00542776 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 262-participant average among 12 other Inflammatory Bowel Disease (IBD) trials with a reported enrollment target (44% lower). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Inflammatory Bowel Disease (IBD) appearing as the primary indexed condition, and to 1 intervention - of which blood draw is the first listed.
NCT00542776 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00542776 about?
NCT00542776 is a clinical study titled "Impact of Immunosuppression in IBD Patients on Response to Influenza Vaccine". The purpose of this study is to compare the efficacy and safety of influenza vaccine in patients with inflammatory bowel disease (IBD) on immunosuppressive therapy with IBD patients on aminosalicylates and healthy historical controls.
What is the current status of trial NCT00542776?
This trial is currently completed. The enrollment target is 146 participants. The study started on 2007-10. Estimated completion is 2008-02.
What conditions does trial NCT00542776 study?
This clinical trial studies the following conditions: Inflammatory Bowel Disease (IBD), Influenza Vaccine, Immunosuppressed or Non-Immunosuppressed, Antibody Titers, Seroprotective Titers.
What interventions are being tested in trial NCT00542776?
The interventions under investigation include: blood draw (OTHER).
Who is sponsoring clinical trial NCT00542776?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00542776 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammatory Bowel Disease (IBD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
RECRUITING
-
Study of DISC-0974-201 in Participants With IBD and Anemia
RECRUITING · Phase 2
-
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
RECRUITING
-
Evaluation of the SMART IBD App in Pediatric IBD
RECRUITING · NA
-
IBD Pregnancy Registry
RECRUITING
-
Family Members At INcreased-risk for Developing Inflammatory Bowel Disease
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.